Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro

European Journal of Pharmacology

Volumn 251, Issue 2-3, 1994, Pages 143-150

  Herbert, Jean Marc ^a   Delisée, Chantal ^a   Dol, Frédérique ^a   Schaeffer, Paul ^a   Cazaubon, Catherine ^a   Nisato, Dino ^a   Chatelain, Pierre ^a  

^a SANOFI   (France)

Author keywords

Angiotensin II; DuP 753; Proliferation; Smooth muscle cell; SR 47436

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; CALCIUM; IRBESARTAN; LOSARTAN; LOSARTAN POTASSIUM; RADIOLIGAND; RECEPTOR SUBTYPE;

AORTA; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; SERUM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; BIPHENYL COMPOUNDS; CALCIUM; CELL DIVISION; CELLS, CULTURED; HUMAN; IMIDAZOLES; IODINE RADIOISOTOPES; LOSARTAN; MITOGENS; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0028155978     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)90394-8     Document Type: Article

References (43)

1. Stimulation of platelet-derived growth factor-induced DNA synthesis by angiotensin II in rabbit vascular smooth muscle cells
2. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, Losartan
3. Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle
4. In vitro effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells
5. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro
6. Cytosolic free calcium levels in monolayers of cultured rat aortic smooth muscle cells
7. Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter
8. 1 subtype angiotensin II receptor antagonist
9. 50) of an enzymatic reaction
10. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent
11. Dup 532: a second generation of nonpeptide angiotensin II receptor antagonists
12. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
13. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function
14. The inhibition of cultured smooth muscle cell growth by saralasin
15. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF
16. Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension
17. Angiotensin II induces hypertrophy, not hyperplasia on cultured rat aortic smooth muscle cells
18. ++ indicators with greatly improved fluorescence properties
19. Functional angiotensin II receptors in cultured vascular smooth muscle cells
20. Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells.
21. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury
22. + concentration changes evoked by angiotensin II and vasopressin in individual rat aortic smooth muscle cells
23. Losartan, a nonpeptide angiotensin II receptor antagonist, inhibits neointima formation following ballon injury to rat carotid arteries
24. Angiotensin receptors in cultured rat aortic smooth muscle (A-10) cells
25. Production of platelet derived growth factor mitogen by smooth muscle cells from human atheroma
26. Role of basic fibroblast growth factor in vascular lesion formation
27. Protein measurement with the Folin phenol reagent
28. PDGF ligand and receptor gene expression during repair of arterial
29. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
30. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells
31. Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulfate and related compounds
32. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
33. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition
34. Suppression of the vascular response to injury: The role of angiotensin-converting enzyme inhibitors
35. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells
36. 1 receptor antagonist
37. Reidy, M.A., Factors controlling smooth muscle cell proliferation, Arch. Pathol. Lab. Med. 116, 1276.
38. The pathogenesis of atherosclerosis. An update
39. Replication of smooth muscle cells in vascular disease
40. 1 receptor confers growth properties to angiotensin II in chinese hamster ovary cells
41. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells
42. Preliminary biochemical characterization of two angiotensin II receptor subtypes